| A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm (NCT05048160) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-09-27 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer (NCT03203525) | M.D. Anderson Cancer Center | 2020-06-23 |
| Cordotomy in Reducing Pain in Patients With Advanced Cancer (NCT04119037) | M.D. Anderson Cancer Center | 2019-09-16 |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336) | Kura Oncology, Inc. | 2019-09-12 |
| Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574) | National Cancer Institute (NCI) | 2019-07-16 |
| Financial Distress in Advanced Cancer Patients (NCT04053517) | M.D. Anderson Cancer Center | 2019-07-02 |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits (NCT03856060) | M.D. Anderson Cancer Center | 2019-03-30 |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings (NCT04186884) | M.D. Anderson Cancer Center | 2019-03-26 |
| Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers (NCT03868423) | Sameek Roychowdhury | 2019-03-20 |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center (NCT03671226) | M.D. Anderson Cancer Center | 2018-09-28 |
| Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer (NCT03592459) | M.D. Anderson Cancer Center | 2018-08-08 |
| A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy (NCT03525873) | M.D. Anderson Cancer Center | 2018-08-02 |
| RCT of QPS vs General Information Sheet (NCT03287492) | M.D. Anderson Cancer Center | 2017-09-25 |
| Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin (NCT03122886) | Mayo Clinic | 2017-07-14 |
| Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer (NCT03021486) | M.D. Anderson Cancer Center | 2017-06-05 |
| First-in-Human Study of KO-947 in Non-Hematological Malignancies (NCT03051035) | Kura Oncology, Inc. | 2017-04-06 |
| Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer (NCT03049397) | Fred Hutchinson Cancer Center | 2017-04-05 |
| Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer (NCT02940223) | M.D. Anderson Cancer Center | 2017-03-16 |
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor (NCT03069469) | Deciphera Pharmaceuticals, LLC | 2017-02-16 |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery (NCT02583269) | Wake Forest University Health Sciences | 2016-03-01 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children (NCT02650583) | University of Washington | 2015-12-28 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687) | M.D. Anderson Cancer Center | 2014-12-22 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer (NCT01582191) | M.D. Anderson Cancer Center | 2012-05-14 |
| The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (NCT01549067) | Chinese Medical Doctor Association | 2011-09-01 |
| Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer (NCT00244972) | National Cancer Institute (NCI) | 2005-10-01 |
| Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors (NCT06872489) | Second Life Therapeutics | |